Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomised and cross-over study in healthy volunteers

Trial Profile

Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomised and cross-over study in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2013

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Intra-abdominal infections; Pelvic inflammatory disorders; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top